Brian Conroy, MD
Orthopaedic Surgery · Omaha, NENPI 1528098613
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Arthrex at 37.1% of the total. Reporting peaked in 2022 at $1,694 and has fallen 69.8% since, to $512 in 2025.
Across 65 payments — averaging $78.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Zimmer Biomet$2K
- Stryker$393
- Vericel Corporation$337
- Conetic Solutions, Inc.$133
- Smith+Nephew$123
- plus $494 from 17 others
What the payments were for
- Travel & lodging$2,13942%
- Food & beverage$1,76435%
- Education$1,20024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $1,893 |
| Zimmer Biomet | 12 | $1,729 |
| Stryker | 10 | $393 |
| Vericel Corporation | 4 | $337 |
| Conetic Solutions, Inc. | 3 | $133 |
| Smith+Nephew | 4 | $123 |
| Ferring Pharmaceuticals Inc. | 5 | $93 |
| ERMI LLC | 1 | $65 |
| Amgen | 1 | $65 |
| Polynovo North America LLC | 2 | $35 |
| Mallinckrodt Enterprises LLC | 2 | $31 |
| Treace Medical Concepts, Inc. | 1 | $24 |
| SPR Therapeutics, Inc | 1 | $24 |
| Vertex | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Si-bone, Inc. | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Heraeus Medical, LLC. | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,103 in reported general payments places this provider in the 60th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $129 |
| Meloxicam | 16 | $70 |
| Ibuprofen | 11 | $56 |
| Amoxicillin | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Omaha
- Edward FehringerOmaha$2M
- Joshua UrbanOmaha$475K
- Sayfe JassimOmaha$460K
- Beau KildowOmaha$353K
- Matthew DilisioOmaha$58K
- Samuel DubrowOmaha$34K
- Jonathan BuzzellOmaha$33K
- Michael StojanovicOmaha$22K
- Kirk HuttonOmaha$15K
- Sean McGarryOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.